期刊文献+

局部晚期直肠癌术前放疗的病理和临床研究 被引量:2

Pathological and Cinical Research on Preoperadve Radio Therapy for Local Advanced Rectal Cancer
下载PDF
导出
摘要 目的:观察局部晚期直肠癌术前放疗后病理学变化和临床疗效。方法:选择我院2005年6月至2007年10月收治的肿瘤局部粘连或固定的直肠癌患者44例,采用随机分组,其中22例行术前放疗(放疗组),另外22例行单纯手术治疗。采用6MVX线加大分割的三维适形放疗,DT:46Gy/20f,放疗后4~6周手术。结果:放疗组术后病理证实:直肠癌消退分级1级占5例,2级占16例,3级占1例。临床分期变化:T期下降15例(68.2%),手术切除率放疗组和手术组分别为86.4%、63.6%,P〈0.05,差异有显著性。术前放疗反应可耐受.且并未增加远期并发症。结论:局部晚期直肠癌术前放疗可提高肿瘤手术切除率,降期显著,并不增加手术难度和并发症。 Objective:To investigate the pathologic changes and clinical effects of preoperative irradiation on local advanced rectal cancer. Methods: From June 2005 to Octobor 2007, 44patients with tethered and fixed rectal cancer were randomly divided into tWO groups. 22 patients were treated by preoprative radiotherapy(the irradiation group), and the others 22 were treated by operation alone. The irradiation group received 6 MV X ray three-dimension conformal radiation therapy, witll total tumor dose(DT)of 46Gy/20f/4W. The operation was per- formed 4-6 weeks after radiation. Results: In the irradiation group, the pathologic response after operation prove: the significant tumor regression(RCRG1)was seen in 5 cases, the partially tumor regression(RCRG2)was seen in 1 6 cases, and 1 case was RCRG3. T- stage was lowered in 15 of patients. The tumor operative resective rate in irradiation group and operation group was 86.4 %, 63.6 %. Conclusions: Preoperative irradiation might enhance the tumor operative resective rate in tethered and fixed rectal cancer. It Can reduce T - stage significantly. And the acute radiation toxicitv was tolerable without increasing operative difficulty and complications.
出处 《内蒙古医学杂志》 2007年第12期1436-1437,共2页 Inner Mongolia Medical Journal
关键词 直肠癌 术前放疗 手术切除率 术后病理学分析 Rectal cancer Preoperative irradiation Operativeresective rate Pathological changes after operadon
  • 相关文献

参考文献3

  • 1范敏,唐宗江.低位直肠癌新辅助治疗的研究进展[J].结直肠肛门外科,2006,12(2):122-124. 被引量:5
  • 2Wheeler JMD,Warren BF,Mortensen NJM,et al.Uuantification ot histologi C regresslon ot rectal cancer atterirradiation[J].Dis Colon Rectum,2002,45(8):1051.
  • 3胡逸民 见:胡逸民 杨定宇主编.适形放射治疗[A].见:胡逸民,杨定宇主编.肿瘤放射治疗技术[C].北京:北京医科大学中国协和医科大学联合出版社,1999.98,102.

二级参考文献23

  • 1邓艳红,詹文华.结直肠癌新辅助治疗的新进展[J].中国实用外科杂志,2005,25(5):310-312. 被引量:21
  • 2Wilke H,Preusser P,Fink U,et al. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer a phase study with etoposide, doxorubicin, and cisplatin. J Clin Oncol,1989,7(9) :1318-1326.
  • 3Foo KF, Micheal M, Zalcberg J. Adjuvant therapy for rectal cancer. Sem in Colon Rectum Surg,2002,13(4):259-268.
  • 4Schuhmach C, Fink U, Siewert JR. Preoperative downstaging in advanced stomach. Wishful thinking or reality. Zentralbl Chir,2000,125(4):333-334.
  • 5Geh JI, Glynne Jones R, Kwok QS, et al. Preoperative ELV chemotherapy in gastro-oesophageal adenocarcinoma. Clin Oneol,2000,12(3):182-187.
  • 6Kohnoe S, Kakeji Y, Maehara Y. Progress in adjuvant therapy for colorectal cancer. Gan To Kagaku Ryoho,2002, 29(13) :2488-2497.
  • 7Pozzo C, Basso M, Cassano A,et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinie acid in colorectal cancer patients.Ann Oncol,2004,15(6) :933-939.
  • 8Bismuth H,Adam R, Levi F, et al. Resection of nonre-sectable liver metastases from eolorectal cancer after neoadjuvant chemotherapy. Ann Surg, 1996,224 (4) :509-520.
  • 9Twelves C,Wong A, Nowacki MP, et al, Capecitabine as adjuvant treatment for stage colon cancer. N Engl J Med, 2005,352 (26) :2696-2705.
  • 10Andre T,Boni C, Mounedji Boudiaf L,et al. Oxaliplatin,fluorouracil,and teucovorin as adjuvant treatment for colon cancer. N Engl J Med,2004,350(23) :2343-2351.

共引文献10

同被引文献19

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部